Tirzepatide
Dual GIP / GLP-1 receptor co-agonist.
Tirzepatide is a 39-amino-acid synthetic peptide acting as a dual GIP and GLP-1 receptor agonist. Research applications include glucose regulation, lipid metabolism, and body-composition modeling at lower comparative doses than GLP-1 monoagonists.
- Cold-chain shipped
- Lot-specific COA
- Free shipping over $150.00
- 100% purity guarantee
All products sold by KuroAminos are intended strictly for in vitro laboratory research and development purposes. They are not drugs, supplements, food, or cosmetics and have not been approved by the FDA. They are not to be administered to humans or animals under any circumstance. By purchasing from KuroAminos you confirm you are a qualified researcher over 21 years of age and assume full responsibility for the safe handling, storage, and use of these compounds within an appropriate research setting.
Specifications
- Form
- Lyophilized powder
- Size
- 10 mg / vial
- Purity (HPLC)
- >99%
- Appearance
- White lyophilized powder
- Storage
- Refrigerate after reconstitution
- CAS no.
- 2023788-19-2
- Mol. formula
- C225H348N48O68
- Mol. weight
- 4813.45 g/mol
Best suited for
- Dual-pathway metabolic research
Researchers also viewed
View all peptides →Semaglutide
Long-acting GLP-1 receptor agonist for metabolic research.
$69.99
10 mgGLP-3RT
Triple GIP / GLP-1 / Glucagon receptor agonist.
$69.99
20 mgGLP-3RT — 20 mg
Triple GIP / GLP-1 / Glucagon receptor agonist — 20 mg vial.
$114.99
10 × 10 mgGLP-3RT — 10-Vial Kit
Ten 10 mg GLP-3RT vials in a single kit — value pricing for multi-month protocols.
$374.99
Shipping from Princeton, NJ · United States